Correlation Between Pharma Equity and BankIn Bredygt

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharma Equity and BankIn Bredygt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma Equity and BankIn Bredygt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharma Equity Group and BankIn Bredygt Klimaakt, you can compare the effects of market volatilities on Pharma Equity and BankIn Bredygt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma Equity with a short position of BankIn Bredygt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma Equity and BankIn Bredygt.

Diversification Opportunities for Pharma Equity and BankIn Bredygt

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pharma and BankIn is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Equity Group and BankIn Bredygt Klimaakt in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BankIn Bredygt Klimaakt and Pharma Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Equity Group are associated (or correlated) with BankIn Bredygt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BankIn Bredygt Klimaakt has no effect on the direction of Pharma Equity i.e., Pharma Equity and BankIn Bredygt go up and down completely randomly.

Pair Corralation between Pharma Equity and BankIn Bredygt

Assuming the 90 days trading horizon Pharma Equity Group is expected to under-perform the BankIn Bredygt. In addition to that, Pharma Equity is 4.46 times more volatile than BankIn Bredygt Klimaakt. It trades about -0.1 of its total potential returns per unit of risk. BankIn Bredygt Klimaakt is currently generating about 0.09 per unit of volatility. If you would invest  10,585  in BankIn Bredygt Klimaakt on September 3, 2024 and sell it today you would earn a total of  180.00  from holding BankIn Bredygt Klimaakt or generate 1.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy80.95%
ValuesDaily Returns

Pharma Equity Group  vs.  BankIn Bredygt Klimaakt

 Performance 
       Timeline  
Pharma Equity Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharma Equity Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
BankIn Bredygt Klimaakt 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BankIn Bredygt Klimaakt are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, BankIn Bredygt may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pharma Equity and BankIn Bredygt Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharma Equity and BankIn Bredygt

The main advantage of trading using opposite Pharma Equity and BankIn Bredygt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma Equity position performs unexpectedly, BankIn Bredygt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BankIn Bredygt will offset losses from the drop in BankIn Bredygt's long position.
The idea behind Pharma Equity Group and BankIn Bredygt Klimaakt pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios